ALB and diabetic kidney disease: Pyridoxamine inhibits the generation of hydroxyl radical from the albumin–Amadori system and thereby protects the albumin–Amadori-induced tryptophan modification and exerts its protective effects on diabetes complications, including diabetic nephropathy [113,114].